Showing results (421-430 of 511) with videos related to

Sort By:
Pageof 52
Inflammatory Bowel Diseases|October 18, 2018
Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of SeverityDjuna C de Jong, Mark Löwenberg, Ioannis Koumoutsos, et al.
ACS Catalysis|February 26, 2026
Mn-Promoted Co/TiO2 Catalysts: Quantitative Analysis of Cobalt Polymorphs and Stacking Faults and Its Effect on Fischer-Tropsch Synthesis PerformanceDanial Farooq, Lucy Costley-Wood, Sebastian Stockenhuber, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2013
Factors associated with thiopurine non-adherence in patients with inflammatory bowel diseaseJ R Goodhand, N Kamperidis, B Sirwan, et al.
Gastroenterology & Hepatology|October 1, 2011
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe GroupMiles P Sparrow, Peter M Irving, Leonard Baidoo, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 27, 2011
Factors associated with nonadherence to thiopurines in adolescent and adult patients with inflammatory bowel diseaseN Kamperidis, J R Goodhand, F A Chowdhury, et al.
Alimentary Pharmacology & Therapeutics|July 5, 2021
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switchRaphael P Luber, Rhona O'Neill, Sukhpreet Singh, et al.
Mabs|July 8, 2022
Mechanistic insights into the rational design of masked antibodiesCarolina T Orozco, Manuela Bersellini, Lorraine M Irving, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 6, 2022
Cyclin-dependent Kinase 9 as a Potential Target for Anti-TNF-resistant Inflammatory Bowel DiseaseOmer S Omer, Arnulf Hertweck, Luke B Roberts, et al.
Australian Veterinary Journal|February 18, 2024
Retrospective assessment of ophthalmic disease development in domestic dogs and cats when hospitalised with tick paralysis caused by Ixodes holocyclusB D Reynolds, E Perry, H G Nagel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 26, 2024
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 TrialsJean-Frédéric Colombel, Ana P Lacerda, Peter M Irving, et al.
Pageof 52